Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus

Acta Diabetologica

Volumn 35, Issue 2, 1998, Pages 96-100

  Calo L ^a   Davis, P A ^b   Cantaro, S ^a   Bonfante, L ^a   Castrignano, R ^a   Carraro, G ^a   D'Angelo, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Doxazosin; Hypertension; Insulin dependent diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; DOXAZOSIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RISK; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DOXAZOSIN; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031666899     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050111     Document Type: Article

References (24)

1. Kannel WB (1986) Hypertension: relationship with other risk factors. Drugs 31 [Suppl 1]:1-11
2. Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of atherosclerotic disease. New perspectives based on Framingham Study. Ann Int Med 90:85-91
3. Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Pennert K, Wedel H, Wikstrand J, Berglund G (1985) Predictors of cardiovascular morbidity in treated hypertension: results from the primary prevention trial in Goteborg, Sweden. J Hypertens 3:167-176
4. Epstein FH (1985) Hyperglycaemia as a risk factor for coronary heart disease. Monogr Atheroscler 13:92-97
5. Wilson PWF, Cupples L, Kannel WB (1991) Is hyperglycaemia associated with cardiovascular disease? The Framingham Study. Am Heart J 2:586-590
6. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC (1992) Association of HbA1C with prevalent cardiovascular disease in the original cohort of the Framingham Heart study. Diabetes 41:202-208
7. Consensus statement (1992) Role of cardiovascular risk factor in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 15 [Suppl 2]:68-74
8. Peiris AN, Gustafson AB (1986) Current therapeutic concepts in diabetic hypertension. Diabetes Care 9:409-414
9. Garg A (1994) Management of dyslipidemia in IDDM patients. Diabetes Care 17:224-234
10. Weidmann P, Uehlinger DE, Gerber A (1985) Antihypertensive treatment and serum lipoproteins. J Hypertens 3:297-306
11. Lardinois CK, Neumann SL (1988) The effect of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med 148:1280-1288
12. Murphy MB, Lewis PJ, Kolner E, Schumer B, Dollery CT (1982) Glucose intolerance in hypertensive patients treated with diuretics: a fourteen year follow-up. Lancet 2:1293-1295
13. Houston MC (1988) The effect of antihypertensive drugs on glucose intolerance in hypertensive non diabetics and diabetics. Am Heart J 115:640-656
14. Roberts WC (1988) Recent studies on the effects of beta blockers on blood lipid levels. Am Heart J 117:709-714
15. Lund-Johansen P, Hjermann I, Iversen BM, Thaulow E (1993) Selective alpha-1 inhibitors: first- or second-line antihypertensive agents? Cardiology 83:150-159
16. Holland OB, Nixon JV, Kuhnert L (1981) Diuretic-induced ventricular ectopic activity. Am J Med 70:762-768
17. Leese GP, Savage MW, Chattington PD, Vora JP (1996) The diabetic patient with hypertension. Postgrad Med J 72:263-268
18. Giles TD (1992) Antihypertensive therapy and cardiovascular risk. Are all antihypertensives equal? Hypertension 19:124-129
19. Taylor SH (1988) Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction. Am Heart J 116:1735-1748
20. Castrignano R, D'Angelo A, Pati T, Al Awady M, Tronca R, Crepaldi G (1988) A single-blind study of doxazosin in essential hypertensive patients with concomitant non insuline-dependent diabetes mellitus. Am Heart J 116:1778-1784
21. Helgeland A (1980) Treatment of mild hypertension: a five year controlled drug trial: the Oslo Study. Am J Med 69:725-732
22. Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Br Med J 291:97-104
23. Kannel WB (1987) Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 59:80-90
24. Kannel WB, Ward GW (1985) A decade of advances in preventive cardiology Primary Cardiol II:19-34